+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Dry Eye Clinical Trial Pipeline Highlights - 2019

  • ID: 4773833
  • Report
  • March 2019
  • Region: Global
  • Fore Pharma
1 of 2
This report, Dry Eye Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Dry Eye market. It covers emerging therapies for Dry Eye in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Dry Eye pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Dry Eye pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Dry Eye pipeline products by the company.

Short-term Launch Highlights:

Find out which Dry Eye pipeline products will be launched in the US and Ex-US till 2024.

Summary:
  • Dry Eye phase 3 clinical trial pipeline products
  • Dry Eye phase 2 clinical trial pipeline products
  • Dry Eye phase 1 clinical trial pipeline products
  • Dry Eye preclinical research pipeline products
  • Dry Eye discovery stage pipeline products
  • Dry Eye pipeline products short-term launch highlights

Note: Please allow up to 48 hours for delivery after order is placed.
Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1. Dry Eye Pipeline by Stages

2. Dry Eye Phase 3 Clinical Trial Insights

3. Dry Eye Phase 2 Clinical Trial Insights

4. Dry Eye Phase 1 Clinical Trial Insights

5. Dry Eye Preclinical Research Insights

6. Dry Eye Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables:
Table 1: Dry Eye Phase 3 Clinical Trials, 2019
Table 2: Dry Eye Phase 2 Clinical Trials, 2019
Table 3: Dry Eye Phase 1 Clinical Trials, 2019
Table 4: Dry Eye Preclinical Research, 2019
Table 5: Dry Eye Discovery Stage, 2019

List of Figures:
Figure 1:: Dry Eye Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Dry Eye Phase 3 Clinical Trial Highlights, 2019
Figure 3: Dry Eye Phase 2 Clinical Trial Highlights, 2019
Figure 4: Dry Eye Phase 1 Clinical Trial Highlights, 2019
Figure 5: Dry Eye Preclinical Research Highlights, 2019
Figure 6: Dry Eye Discovery Stage Highlights, 2019
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll